Literature DB >> 30843223

Annual Research Review: Does late-onset attention-deficit/hyperactivity disorder exist?

Philip Asherson1, Jessica Agnew-Blais1.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is conceptualized as an early onset childhood neurodevelopmental disorder. Prevalence in adults is around two-thirds that in childhood, yet longitudinal outcome studies of children with ADHD found a minority continue to meet full criteria in adulthood. This suggests that not all adult cases meet ADHD criteria as children, a conclusion supported by earlier studies relying on retrospective recall in adolescent and adult samples. More recently prospective follow-up of population and control samples suggest that adolescent and young adult ADHD is not always a continuation of childhood ADHD. Here, we review the literature on age of onset, to explore whether late-onset ADHD exists, and if so, examine the evidence for whether this should be considered the same or a different disorder as childhood onset ADHD. We conclude that current evidence supports the view that a significant proportion of young adults meeting criteria for ADHD would not have met full diagnostic criteria for ADHD as children. However, many in the late-onset group show some ADHD symptoms in childhood, or an externalizing disorder such as oppositional defiant disorder. Furthermore, the current studies suggest that most (but not all) cases of late-onset ADHD develop the disorder between the ages of 12-16 and can therefore be considered adolescent or early adult onset ADHD. There is a relative lack of data spanning young to older adulthood to address the question of adult-onset. Currently, there is insufficient data to clarify the extent to which early and late onset ADHD reflect a different balance of genetic and environmental risks or share the same underlying neural mechanisms. Clinicians should be aware that significantly impairing forms of ADHD can emerge beyond the age of 12 years, although perhaps rarely in the context of a complete absence of precursors. The current evidence on treatment responses is limited.
© 2019 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.

Entities:  

Keywords:  zzm321990ADHDzzm321990; developmental epidemiology; developmental psychopathology; longitudinal studies

Mesh:

Year:  2019        PMID: 30843223     DOI: 10.1111/jcpp.13020

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  26 in total

1.  Examining the Role of Genetic Risk and Longitudinal Transmission Processes Underlying Maternal Parenting and Psychopathology and Children's ADHD Symptoms and Aggression: Utilizing the Advantages of a Prospective Adoption Design.

Authors:  Ruth Sellers; Gordon T Harold; Anita Thapar; Jenae M Neiderhiser; Jody M Ganiban; David Reiss; Daniel S Shaw; Misaki N Natsuaki; Leslie D Leve
Journal:  Behav Genet       Date:  2020-07-04       Impact factor: 2.805

2.  Is quality of life related to high autistic traits, high ADHD traits and their Interaction? Evidence from a Young-Adult Community-Based twin sample.

Authors:  Simone J Capp; Jessica Agnew-Blais; Alex Lau-Zhu; Emma Colvert; Charlotte Tye; Ümit Aydin; Alexandra Lautarescu; Claire Ellis; Tyler Saunders; Lucy O'Brien; Angelica Ronald; Francesca Happé; Gráinne McLoughlin
Journal:  J Autism Dev Disord       Date:  2022-07-08

3.  Differences in the genetic architecture of common and rare variants in childhood, persistent and late-diagnosed attention-deficit hyperactivity disorder.

Authors:  Veera M Rajagopal; Jinjie Duan; Laura Vilar-Ribó; Jakob Grove; Tetyana Zayats; J Antoni Ramos-Quiroga; F Kyle Satterstrom; María Soler Artigas; Jonas Bybjerg-Grauholm; Marie Bækvad-Hansen; Thomas D Als; Anders Rosengren; Mark J Daly; Benjamin M Neale; Merete Nordentoft; Thomas Werge; Ole Mors; David M Hougaard; Preben B Mortensen; Marta Ribasés; Anders D Børglum; Ditte Demontis
Journal:  Nat Genet       Date:  2022-08-04       Impact factor: 41.307

Review 4.  Toward Precision Medicine in ADHD.

Authors:  Jan Buitelaar; Sven Bölte; Daniel Brandeis; Arthur Caye; Nina Christmann; Samuele Cortese; David Coghill; Stephen V Faraone; Barbara Franke; Markus Gleitz; Corina U Greven; Sandra Kooij; Douglas Teixeira Leffa; Nanda Rommelse; Jeffrey H Newcorn; Guilherme V Polanczyk; Luis Augusto Rohde; Emily Simonoff; Mark Stein; Benedetto Vitiello; Yanki Yazgan; Michael Roesler; Manfred Doepfner; Tobias Banaschewski
Journal:  Front Behav Neurosci       Date:  2022-07-06       Impact factor: 3.617

Review 5.  ADHD in Children and Adults: Diagnosis and Prognosis.

Authors:  Douglas Teixeira Leffa; Arthur Caye; Luis Augusto Rohde
Journal:  Curr Top Behav Neurosci       Date:  2022

6.  Pharmacist Medication Management of Adults with Attention Deficit: An Alternative Clinical Structure.

Authors:  Rex Huang; Samuel J Ridout; Brooke Harris; Kathryn K Ridout; Kavitha Raja
Journal:  Perm J       Date:  2020-03-18

7.  Variable Emergence of Autism Spectrum Disorder Symptoms From Childhood to Early Adulthood.

Authors:  Lucy Riglin; Robyn E Wootton; Ajay K Thapar; Lucy A Livingston; Kate Langley; Stephan Collishaw; Jack Tagg; George Davey Smith; Evie Stergiakouli; Kate Tilling; Anita Thapar
Journal:  Am J Psychiatry       Date:  2021-04-26       Impact factor: 18.112

Review 8.  Attention-deficit hyperactivity disorder.

Authors:  Jonathan Posner; Guilherme V Polanczyk; Edmund Sonuga-Barke
Journal:  Lancet       Date:  2020-01-23       Impact factor: 202.731

Review 9.  Adolescent Attention-Deficit/Hyperactivity Disorder: Understanding Teenage Symptom Trajectories.

Authors:  Philip Shaw; Gustavo Sudre
Journal:  Biol Psychiatry       Date:  2020-06-14       Impact factor: 13.382

10.  Associations between ADHD and emotional problems from childhood to young adulthood: a longitudinal genetically sensitive study.

Authors:  Adi Stern; Jessica C Agnew-Blais; Andrea Danese; Helen L Fisher; Timothy Matthews; Guilherme V Polanczyk; Jasmin Wertz; Louise Arseneault
Journal:  J Child Psychol Psychiatry       Date:  2020-02-29       Impact factor: 8.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.